{"database": "lobbying", "table": "lobbying_activities", "rows": [[2189132, "46b8e9db-d97a-4d1a-8098-b39a749ecac6", "Q3", "NATIONAL COMMUNITY PHARMACISTS ASSOCIATION", 27478, "NATIONAL COMMUNITY PHARMACISTS ASSOCIATION", 2018, "third_quarter", "PHA", "Congressional Oversight of 340 B Program; \nIssues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; \nBiosimilar naming; \nH.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; \nH.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017;\nHR 749, Lower Drug Costs through Competition Act;\nEPA Proposed Rule: Management Standards for Hazardous Waste Pharmaceuticals", "Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),Office of Personnel Management (OPM),SENATE,Small Business Administration (SBA),Substance Abuse & Mental Health Services Administration (SAMHSA),White House Office", null, 290000, 0, 0, "2018-10-17T16:57:24.270000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2189132"], "units": {}, "query_ms": 88.44628394581378, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}